Lyra Therapeutics
lyratherapeutics.com
Actively hiring
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$184.5M
4 rounds on record
Latest round
$50M
Venture round · May 2023 · 3 yr ago
Team
30
US Form 5500 (plan participants) · Dec 2025 · -14% in a year
Backers
1
Broadview Ventures
The money's age
Long since its last round
40 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 25, 2023
Raised a round Venture round $50M · SEC Form D
Apr 12, 2022
Raised a round Venture round $100.5M · SEC Form D
Jan 10, 2020
Raised a round Venture round $28M · SEC Form D
Nov 10, 2016
Raised a round Venture round $6M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | May 2023 | $50M | — | SEC Form D |
| Venture round | Apr 2022 | $100.5M | — | SEC Form D |
| Venture round | Jan 2020 | $28M | — | SEC Form D |
| Venture round | Nov 2016 | $6M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Lyra Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Maria Palasis Ph.D.Executive Officer, DirectorSEC Form D
Don ElseyExecutive OfficerSEC Form D
Harlan Waksal M.D.Executive Officer, DirectorSEC Form D
Jason CavalierExecutive OfficerSEC Form D
Robert Richard Ph.D.Executive OfficerSEC Form D
Pamela NelsonExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Broadview Ventures Similar startupsby what they do, their industry and backers
Redefining Complement Therapies. Complement Therapeutics is a clinical-stage biotechnology company advancing precision therapies for…
AAVantgarde is a clinical-stage biotechnology company developing next-generation therapies for inherited retinal diseases with high unmet…
Advancing reversible therapies targeting von Willebrand Factor for safer treatment of acute thrombotic conditions. Precision control when…
Kailera is a late clinical-stage biotechnology company advancing a diversified pipeline of GLP-1 therapies to provide options for people…
Juvena Therapeutics is a clinical-stage biotechnology company engineering proteins that human stem cells naturally secrete into…
BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial…
News
Lyra Therapeutics stock holds its Nasdaq listing as results await
Lyra Therapeutics stock closed at a Nasdaq price dated September 22, 2026, while its latest reported period provides the operating baseline. The company remains a clinical-stage biotech.
Read more
Report
Lyra Therapeutics stock holds steady as investors eye recent trial and cash runway
Lyra Therapeutics stock reflects a biotech in transition as of September 20, 2026, with investors focused on its nasal drug delivery pipeline and cash runway. The company's recent clinical progress and financing history frame the current risk-reward profi
Read more
Report
Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates
Lyra Therapeutics (LYRA) delivered earnings and revenue surprises of +4.84% and +26.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Maria Palasis Ph.D.
Executive Officer, Director
Don Elsey
Executive Officer
Harlan Waksal M.D.
Executive Officer, Director
Jason Cavalier
Executive Officer
Robert Richard Ph.D.
Executive Officer
Pamela Nelson
Executive Officer
Corinne Noyes
Executive Officer
Richard Nieman M.D.
Executive Officer
John Bishop Ph.D.
Executive Officer
Maria Palasis
Director, Executive Officer
Konstantin Poukalov
Director
Ann Merrifield
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Watertown
United States
HQ
Our Offices
200-500 est. staff
480 Arsenal Way, Watertown, MA 02472